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Background: This study was designed to identify risk factors for lymph node metastasis of early stage colorectal
cancer, which was confirmed to a carcinoma that invaded the submucosa after radical resection.
Methods: In total, 55 patients revealing submucosal invasive colorectal carcinoma on pathology who underwent
curative radical resection at the Department of Surgery, St. Vincent’s Hospital, The Catholic University of Korea from
January 2007 to September 2010 were evaluated retrospectively. Tumor size, depth of submucosal invasion,
histologic grade, lymphovascular invasion, tumor budding, and microacinar structure were reviewed by a single
pathologist. Student t-test for continuous variables and Chi-square test for categorical variables were used for
comparing the clinicopathological features between two groups (whether lymph node involvement existed or not).
Continuous variables are expressed as the mean ± standard error while statistical significance is accepted at P < 0.05.
Results: The mean age of 55 patients (34 males and 21 females) was 61.2 ± 9.6 years (range, 43–83). Histologically,
eight (14.5%) patients had metastatic lymph node. In the univariate analysis, tumor budding (P = 0.047) was the
only factor that was significantly associated with lymph node metastasis. Also, the tumor budding had a sensitivity
of 83.3%, a specificity of 60.5%, and a negative predictive value of 0.958 for lymph node metastasis in submucosal
invasive T1 colorectal cancer.
Conclusions: The tumor budding seems to have a high sensitivity (83.3%), acceptable specificity (60.5%), and a
high negative predictive value (0.958). A close examination of pathologic finding including tumor budding should
be performed in order to manage early CRC properly.
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An increase in colorectal cancer (CRC) screening and
progress in techniques has resulted greater frequency of
detection of T1 stage CRC. With recent advances in
endoscopic techniques and improved endoscopes, T1
stage CRC and adenomatous polyps are often resected
by endoscopes, regardless of their size or location [1-3].
Local treatments such as endoscopic resection and local
excision are considered adequate management for early
stage CRC without lymph node metastasis. A complete
local treatment of intramucosal carcinoma is accepted as* Correspondence: hmcho@catholic.ac.kr
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reproduction in any medium, provided the ora curative treatment because there is little risk of lymph
node metastasis. However according to the definitions
used by most authors, colorectal adenomas with early
invasive carcinoma contain a carcinoma that invades the
submucosa, but not the muscularis propria. There is a
risk of lymph node metastasis when cancer cells have
invaded the submucosa. [3-6]. Therefore to avoid over-
treatment or under-treatment, histopathological evalu-
ation of locally excised specimens is important.
The previous reported incidence of lymph node metas-
tasis in early stage CRC ranges from 0 to 15.4%, and the
risk factors after endoscopic polypectomy include car-
cinoma at the surgical margin, lymphovascular invasion,
poorly differentiated adenocarcinoma, and level of inva-
sion[7,8]. Recently, some investigators suggested that a. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Representative hematoxyline-eosin (H & E) staining of
tumor budding(arrow) - present case (x 200).
Figure 2 The tumor cells show microacinar structures (small
round tubules) (arrow) (H & E x 400).
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metastasis of early stage CRC including occult metastasis
[9,10].
This study was designed to identify risk factors for
lymph node metastasis of early stage CRC, which was
confirmed to a carcinoma that invade the submucosa
after radical resection.
Methods
A total of 55 patients revealing submucosal invasive
colorectal carcinoma on pathology who underwent cura-
tive radical resection at the Department of Surgery, St.
Vincent’s Hospital, The Catholic University of Korea
from January 2007 to September 2010 were evaluated
retrospectively. After obtaining the review board ap-
proval from our institute(VC11RISE0171), demographics
and pathologic findings of 55 patients were reviewed
retrospectively.
In this study, all tumors were macroscopically polyp-
oid type which protruded above the surrounding surface
at endoscopic finding. These tumors were classified into
three different kinds: Ip, Isp, and Is. Ip is an abbreviation
for pedunculated polyp which the base is narrow. Isp is
an intermediate and broad-based forms. Lastly, Is is a
sessile polyp which the base and the top of the lesion
have the same diameter [11]. We defined the right sided
colon as cecum, ascending, hepatic flexure, and proximal
transverse colon. And the left sided colon was defined
as mid to distal transverse, descending, sigmoid, and
rectosigmoid colon. The circumferential ratio of the
tumor represents the ratio of circumference of tumor to
luminal circumference. All pathologic slides were re-
examined in which tumor size, depth of submucosal in-
vasion, histologic grade, lymphovascular invasion, tumor
budding, and microacinar structure by a single patholo-
gist. The depth of submucosal invasion was defined as
the depth between muscularis mucosae and deep tumor
margin measured in micrometers. Also, Kudo’s classifi-
cation was used with the relative invasion depth of the
submucosal layer and they are as follow: sm1, infiltration
into the upper third of the submucosal layer; sm2, mid-
dle third; or sm3, lower third [4]. Histologic grade was
classified in the order of well, moderately, poorly differ-
entiated, and mucinous adenocarcinoma. Lymphovascu-
lar invasion is defined as the presence of tumor cells
within small luminal structures lined by endothelial
cells. An isolated cell or a small cluster of carcinoma
cells in the invasive front is determined by looking at a
budding focus, which when viewed at a 200-fold magni-
fication, > 10 budding foci was considered as positive
for tumor budding (Figure 1). Finally microacinar struc-
ture specifies small tubules that form cribriform struc-
tures within the medium or large glands, or small
isolated round tubules within the stroma (Figure 2) [12].Student t-test for continuous variables and Chi-square
test for categorical variables were used for comparing
the clinicopathological features between two groups
whether lymph node involvement existed or not. Con-
tinuous variables are expressed as the mean ± standard
error whereas statistical significance is accepted at
P < 0.05. The applied statistical software was SPSSW 12.0
(SPSS Inc., Chicago, IL, USA).
Results
There were a total of 55 patients including 34 males
and 21 females. The mean age of the patients was
61.2 ± 9.6 years (range, 43–83). Histologically, eight
patients (14.5%) had metastatic lymph node. The mean
tumor size (the largest diameter) was 2.3 ± 1.4 cm
(range, 0.7-8.0 cm). Table 1 shows the clinicopathologi-
cal features in patients with early CRC with submucosal
invasion. In the univariate analysis, the lymph node me-
tastasis was significantly associated with the tumor bud-
ding (P = 0.047) while other factors were not statistically
Table 1 Risk factor for lymph node metastasis in patients with submucosal invasive colorectal cancer
Lymph node involvement P-value
No (n = 47) Yes (n = 8) Univariate Multivariate
Age Mean± S.D. 60.8 ± 9.7 64.0 ± 8.9 0.381
Sex male 29 (61.7 %) 5 (62.5 %)
female 18 (38.3 %) 3 (37.5 %) 0.966
Tumor location Rt. Sided colon{ 6 (12.8 %) 2 (25.0 %)
Lt. Sided colon} 22 (46.8 %) 4 (50.0 %)
Rectum 19 (40.4 %) 2 (25.0 %) 0.345
Macroscopic shape of Ip 23 (48.9 %) 3 (37.5 %)
tumor Isp 9 (19.1 %) 1 (12.5 %)
Is 12 (25.5 %) 3 (37.5 %) 0.485
Tumor size ≤ 2.3 cm 20 (42.6 %) 5 (62.5 %)
> 2.3 cm 19 (40.4 %) 2 (25.0 %) 0.428
Circumference ratio† ≤ 1/4 26 (55.3 %) 6 (75.0 %)
1/4 < or≤ 2/4 17 (36.2 %) 2 (25.0 %)
2/4 < or≤ 3/4 1 (2.1 %) 0
> 3/4 0 0 0.375
Depth of invasion (μm) < 1000 1 (2.1 %) 0
1000≤ or < 2000 6 (12.8 %) 2 (25.0 %)
2000≤ or < 3000 10 (21.3 %) 0
3000 ≤ 23 (48.9 %) 4 (50.0 %) 0.435 0.282
Depth of invasion (by Sm1 12 (25.5 %) 2 (25.0 %)
Kudo’s classification) Sm2 17 (36.2 %) 1 (12.5 %)
Sm3 10 (21.3 %) 3 (37.5 %) 0.364 0.063
Differentiation well 21 (44.7 %) 1 (12.5 %)
moderately 21 (44.7 %) 6 (75.0 %)
poorly 0 0 0.112 0.856
Lymphovascular Absent 37 (78.7 %) 4 (50.0 %)
invasion Present 5 (10.6 %) 2 (25.5 %) 0.206 0.232
Tumor budding Absent 23 (48.9 %) 1 (12.5 %)
Present 15 (31.9 %) 5 (75.0 %) 0.047 0.042
Microacinar structure Absent 29 (61.7 %) 3 (37.5 %)
Present 9 (19.1 %) 3 (37.5 %) 0.179 0.247
†= including cecum, ascending, hepatic flexure, and proximal transverse colon.
{= including mid to distal transverse, descending, sigmoid, and rectosigmoid colon.
}= ratio of the circumference of tumor to luminal circumference.
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budding (P = 0.042, Hazard ratio 13.285, Confidence
interval 1.094 – 161.297) was the only independent fac-
tor for lymph node metastasis in early CRC with sub-
mucosal invasion. The tumor budding had a sensitivity
of 83.3% and a specificity of 60.5%. Also, although the
tumor budding had a low positive predictive value
(0.25), it had a negative predictive value of 0.958 for
lymph node metastasis in submucosal invasive T1 colo-
rectal cancer. Although there was not any statistically
significant factor shown in the multivariate analysis, thedepth of invasion by Kudo’s classification (P = 0.063)
was a marginally meaningful predictive factor for lymph
node metastasis in early CRC with submucosal invasion.
In the present study, 22 of 55 patients underwent colo-
noscopic polypectomy before curative radical surgery.
Table 2 shows the causes of radical surgery after colono-
scopic polypectomy. An incomplete polypectomy (45.5%)
was the most frequent reason for a curative radical
surgery.
Table 3 shows the clinicopathological features of eight
patients who had submucosal invasive CRC with lymph
Table 2 Causes of radical resection after colonoscopic
polypectomy
Causes N (=22)
Involved or closed resection margin 10 (45.5 %)
Patient wanted (Sm1 or Sm2) 4 (18.2 %)
No identification of tumor depth,
lymphovascular invasion, or resection margin
3 (13.7 %)
Lymphatic invasion (+) 2 (9.1 %)
No lifting of tumor at trial for polypectomy 1 (4.5 %)
Piecemeal resection 1 (4.5 %)
Sessile polyp c rectal invasive carcinoma 1 (4.5 %)
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patients who underwent colonoscopic polypectomy at a
local clinic before radical surgery could not be found.
The tumor budding was found in five (83.3%) of six
patients whose pathologic data of malignant polyps
could be found. The microacinar structure was found
in three (50%) of six patients. There was one patient
having a recurrence after curative radical surgery. She
underwent laparoscopic low anterior resection for ma-
lignant rectal polyp located 7 cm from the anal verge.
After the curative surgery, she was given an adjuvant
chemotherapy using 5-FU and leucovorin (LF) regimen
after curative surgery, but multiple unresectable liver
metastases were found 3 months later. Although we
gave FOLFOX chemotherapy, the liver metastases pro-
gressed and the patient passed away eleven months
after radical surgery.
Discussion
The progress of endoscopic diagnosis and techniques
has resulted higher frequency of detection of early stage
CRC. With the advances of endoscopic instruments and
techniques, the number of endoscopic resections for
early-stage CRC has increased providing better quality ofTable 3 Clinicopathological features of eight patients who ha
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tumor cell forming in mucosal layer, it is better to per-
form a local treatment without adjuvant therapy because
such cancer rarely metastasizes to the lymph node or
distant organs [6]. With application of endoscopic treat-
ments being widespread, an adverse outcome such as
tumor recurrence was observed occasionally[13,14].
Therefore, this treatment is only adequate for early stage
CRC without lymph node metastasis when the cancer
cells have invaded submucosa [5-7]. In previous studies
reported, the depth of submucosal invasion (Sm3), poor
histologic grade, lymphovascular invasion, and tumor
cell dissociation are labeled to be the risk factors for
lymph node metastasis in submucosal invasive CRC.
Among these factors, the depth of submucosal inva-
sion is an important predictor of lymph node metastasis
[4-7,10,13-16]. There are two ways to measure the depth
of submucosal invasion. First is to directly measure the
vertical distance of submucosal invasion from muscularis
mucosae. When the muscularis mucosae could not be
identified due to carcinomatous invasion, the superficial
aspect of the submucosal invasive carcinoma is used as a
baseline. The other is by measuring a relative depth ap-
plying the Kudo classification [4]. Kitajima et al. [15]
examined 865 submucosal invasive CRCs and analyzed
the correlation between lymph node metastasis and
depth of submucosal invasion. For pedunculated sub-
mucosal invasive CRC, the rate of lymph node metasta-
sis was 0% in head invasion cases and stalk invasion
cases with depth of invasion <3000 μm if lymphatic in-
vasion was negative. For nonpedunculated submucosal
invasive CRC, the rate of lymph node metastasis was
also 0% if the depth of invasion was <1000 μm. Sung
et al. [6] demonstrated that the minimal extent of sub-
mucosal invasion in tumors with lymph node metastasis
was 1840 μm. Based on this finding, they suggested that
when submucosal invasion of an endoscopically resectedd T1 colorectal cancer with lymph node metastases
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achieved by endoscopic resection alone. Kudo et al. [4]
proposed criteria for staging early CRCs in 1984 classify-
ing degrees of submucosal invasion into three types
based on the depth of invasion: sm1 (less than one-third
of the submucosa is invaded), sm2 (intermediate), and
sm3 (more than two-thirds of submucosa is invaded).
For sm1, it is subclassified into sm1 into a, b, and c,
according to the degree of horizontal extension of can-
cer in the submucosal layer. This staging of submucosal
invasion is reflected to the prognosis of lesion. They
reported that the lymph node metastasis was detected
3.7% in sm1c cancers, 10.9% in sm2 cancers, and 23.7%
in sm3 cancers. In present study, eight patients had
metastatic lymph node. However, data of malignant
polyps in two patients who underwent colonoscopic
polypectomy at a local clinic before radical surgery could
not be found. There was no lymph node metastasis in
submucosal invasive CRCs that the depth of invasion
was <1000 μm. In terms of primary tumor with lymph
node metastasis, four (67.7%) of six patients had a depth
of invasion of ≥3000 μm while two patients had depth of
1000 μm and 1500 μm respectively. The lymph node
metastasis was detected in 14.3% of sm1 cancers, 5.6% of
sm2 cancers, and 23.1% of sm3 cancers. Comparing to
other previous studies, the lymph node metastasis was
more frequently detected in sm1 cancers. Based on this
finding, although the depth of invasion is very important
predictive factor for lymph node metastasis in submuco-
sal invasive CRC, other factors such as microscopic
grade, lymphovascular invasion, and tumor budding
should be considered for complete cure by endoscopic
resection alone. Ueno et al. [16] demonstrated that to ex-
tend the criteria for curative endoscopic resection, the
combination of a quantitative factor and qualitative fac-
tors is useful. The quantitative factor is the depth of sub-
mucoal invasion and the qualitative factors include
tumor grade, lymphovascular invasion, tumor budding,
etc. Several studies have reported that the lymphovascu-
lar invasion is one of the histological risk factors for
lymph node metastasis of submucosal invasive CRC
[10,15-17]. In light of the clinical and biological import-
ance of this feature in T1 tumors, American Joint Com-
mittee on Cancer recommended that the following
modification of the T1 category (tumor invades the sub-
mucosa) to be used: T1a (no evidence of lymphatic or
venous invasion) or T1b (lymphatic or venous invasion is
present). However, it will remain problematic as long as
diagnosis continues to differ occasionally among patholo-
gists. Controversies over the detection of lymphovascular
invasion arise mainly from the difficulty in visualizing the
lymphatic vessel wall. It is difficult to detect lymphovas-
cular invasion with conventional hematoxylin and eosin
(HE) staining [18]. To overcome this limitation, Ishiiet al.[19] recommended the use of immunostaining with
some materials such as monoclonal antibody D2-40
demonstrating that such method would provide import-
ant information about the risk of lymph node metastasis
and may prove useful in evaluating the necessity of an
additional resection after local excision in T1 CRCs. In
the present study, lymphovacular invasion was diagnosed
in 7 (14.6%) of 48 cases that were examined only with
HE staining. Lymph node metastasis could be found in 2
(28.6%) of these 7 cases. From our results, we conclude
that a close evaluation for lymphovascular invasion with
immunostaining may be helpful for identifying the risk
factor for lymph node metastasis in submucosal invasive
CRC. Tumor budding is also seen to be another import-
ant parameter in the evaluation of submucosal invasive
CRC. This evaluation for tumor budding has merits in
that evaluation is possible by ordinary HE staining [20].
Also, tumor budding may be a factor related to lympho-
vascular invasion. Morodomi et al. [21] have suggested
that by making serial sections of specimen, budding is
associated with lymphovascular invasion. Moreover,
some reports suggest that the most important factor
regarding the presence of budding is lymphovascular in-
vasion.[22,23] High-grade tumor budding has been con-
sistently linked to lymph node metastasis, distant
metastasis, local recurrence and correlates with the dis-
tance of tumor invasion beyond the outer border of the
muscularis propria. Tumor budding is proposed as a
useful indicator for isolated tumor cells in lymph nodes
in patients with early CRCs and could indicate curative
surgery in patients with locally excised T1 tumors.[24]
Also, microacinar structures (buds of tumor emanating
from larger glands) and undifferentiated cells in stroma
may be the antecedent stages of lymphatic invasion.[21]
Goldstein et al.[12] suggested the association of exten-
sive budding, microacinar structure and undifferentiated
cells along the advancing edge with lymph node metas-
tases. To sum up the findings, it is suggested that one of
qualitative factors may not be detected independently,
but any of those may be detected at progression of
tumor. In other words, the detection of any qualitative
factor is important in predicting lymph node metastasis.
In this study, tumor budding (P= 0.042, Hazard ratio
13.285, Confidence interval 1.094 – 161.297) was the only
independent factor for predicting lymph node metastasis.
Also, although there was no lymph node metastasis in 15
patients with tumor budding (positive predictive value
was 0.25) and not appropriated due to small sample size
of this study, tumor budding seems to have a high sensi-
tivity (83.3%), acceptable specificity (60.5%), and a high
negative predictive value (0.958). We think that a high
negative predictive value may be more important than a
positive predictive value for clinician in order to decide
whether an additional radical resection after local excision
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rectal cancer would be required or not. This finding may
suggested that a close examination of histopathologic
finding would provide important information about the
risk of lymph node metastasis and may prove useful in
evaluating the necessity of an additional resection after
local excision in T1 CRC cases.
Our study does have some limitations. It was a retro-
spective study using the medical records of small num-
ber of patients, and the pathologic review of primary
tumor could not be performed in all patients. Hence,
our results for depth of invasion and lymphovascular in-
vasion as a risk factor for lymph node metastasis were
somewhat different compared with previous reported
studies. Therefore, a large scaled prospective trial is ne-
cessary to verify the management strategy for submuco-
sal invasive CRC.
Conclusion
A close examination of pathologic finding including
quantitative and qualitative factors should be performed
for proper management of submucosal invasive CRC.
Especially, the tumor budding seems to have a high sen-
sitivity (83.3%), acceptable specificity (60.5%), and a high
negative predictive value (0.958) in this study. Therefore,
we think that the examination for tumor budding after
colonoscopic or local excision for submucosal invasive
CRC should be performed routinely. If any risk factor is
detected, additional oncologic surgery would be
necessary.
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